Avadel (AVDL) Drops 6.7% on Lack of Leads
In recent developments, Avadel Pharmaceuticals plc (NASDAQ:AVDL) reached an updated agreement with Alkermes PLC for their proposed merger, after the latter raised its acquisition offer that would value...
Avadel Pharmaceuticals Plc (AVDL)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Knoll Capital Management Fred Knoll | 600,000 | $12,930,000 | 5.93% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.93 | 5,000 | $39,640.00 | 67,900 | 2025-01-21 | Filing | |
| $8.05 | 10,000 | $80,450.00 | 104,055 | 2025-01-13 | Filing | |
| $7.84 | 30,000 | $235,218.00 | 208,900 | 2025-01-13 | Filing | |
| $10.44 | 2,300 | $24,018.67 | 87,800 | 2024-12-13 | Filing | |
| $10.49 | 5,000 | $52,432.50 | 85,500 | 2024-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.00 | 11,112,052 | $233,353,092.00 | 0 | 2026-02-13 | Filing | |
| $14.53 | 75,000 | $1,089,750.00 | 67,025 | 2023-12-28 | Filing | |
| $14.93 | 28,975 | $432,614.14 | 142,025 | 2023-08-11 | Filing | |
| $7.23 | 3,072 | $22,210.56 | 55,765 | 2019-12-12 | Filing | |
| $2.49 | 8,429 | $21,021.93 | 29,538 | 2018-12-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1 | $16 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
Avadel (AVDL) Gets 26% Boost on Takeover Bid
Last Friday, Avadel Pharmaceuticals plc (NASDAQ:AVDL) soared to as much as $23.57—its highest price in more than a decade—before ending the day just up by 22.45 percent at $23.56 apiece, following...
10 Hottest Small Cap Stocks to Buy Now
On November 12, Scott Chronert, Citi's U.S. equity strategist, appeared on a CNBC Television interview to discuss his bullish case for small- and mid-cap stocks.
Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War
Avadel extended its winning streak to a 5th straight day on Friday to hit a new 10-year high as investor sentiment was boosted by its receipt of a new acquisition proposal which appeared to be superior...
Avadel Pharmaceuticals (AVDL) Attracts Institutional Investment
Avadel Pharmaceuticals plc (NASDAQ:AVDL) is among the fastest growing small cap stocks to buy.
Avadel Pharmaceuticals plc (AVDL)’s LUMRYZ™ Sales Surge 64% in Breakout Quarter
Avadel Pharmaceuticals plc (NASDAQ:AVDL), a Dublin-based biopharmaceutical company, is gaining attention in the sleep medicine space with its flagship product LUMRYZ™, the first and only once-at-bedtime...
11 Fastest Growing Small Cap Stocks to Buy
These days, everyone is obsessed with speed: fast fashion, fast food, fast internet.
11 Best Pharma Stocks to Invest in for the Long Term
According to a recent White House announcement, President Trump wrote letters to 17 major pharmaceutical companies outlining the actions they could take to bring the prices of prescription pharmaceuticals...
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to at Avadel Pharmaceuticals Second Quarter 2025 Earnings Call. [Operator Instructions].
Avadel Pharmaceuticals Receives Unanimous Appeals Court Affirmation for LUMRYZ FDA Approval
Avadel Pharmaceuticals (NASDAQ:AVDL) is one of the most undervalued small-cap stocks to buy according to analysts.
Hedge Fund Resource Center